Research shows a heightened risk of NMSC in MPN patients, especially those on ruxolitinib. Regular skin checks are essential. Your donations this May support vital MPN research & are matched! #MPNAwareness #SkinCancerAwareness mpnrf.info/24mmx

For 24 years MPN Research Foundation has delivered on our bold commitment in honor of our founder, Bob Rosen, to
fund research on innovative approaches to prevention, new therapies, and improved quality of life for people living with MPNs. Donate today: mpnrf.info/24mmx

In 24 years, we've gone from barely recognizing MPNs to ET, PV, and MF being at the forefront of cancer research conversation. The journey isn’t over—your support fuels the next breakthroughs. Donate now to propel #MPNresearch : mpnrf.info/24mmx

Imagine a future with no uncertainties re: PV, ET, and MF. Bob Rosen did and that's why he founded MPN Research Foundation. Your donation advances crucial research. Help us meet our $100,000 goal this month. Contribute to pioneering breakthroughs. mpnrf.info/24mmx

'Bob emphasized research should impact patient care,' says Dr. Andrew Schafer. Our 2024 MPN Challenge™ integrates this vision. #MPNChallenge Awardees announcement soon! Join us and let's advance towards a cure together! mpnrf.info/3UF1aDG

Honoring Bob Rosen's legacy in #MPNresearch ! Every #donation will be DOUBLED this May up to $35K to fuel the next groundbreaking discoveries. Join us in pushing forward Bob's vision for better treatments and cures for #MPNs . Donate today: mpnrf.info/24mmx

Your research can be guided by real patient experiences, shaping future treatments. Join us in merging patient insights with scientific progress. Let's innovate together. Subscribe for updates: mpnrf.info/3P2JAX2 #MPNResearch #InnovationThroughCollaboration

Thank you @LLS and @NaveenPemmaraju for shining the light on latest #treatmentadvances for #Myelofibrosis . You can listen to the podcast here: thebloodline.org/TBL/165e165/ #podcast #mpnresources

2019 saw us facilitate a #PFDDmeeting , integrating MPN patient insights into drug development, in partnership with #FDA , #lifesciences , and research experts. Dive into the outcomes and collaborate with us for innovative #MPN treatments moving forward. mpnrf.info/3P2JAX2

A new #study on the deeper understanding of #JAK2 mutations & MPN development highlights the power of cross-institutional #collaboration . Together, we're bridging gaps in #research for transformative solutions. Abstract: pubmed.ncbi.nlm.nih.gov/38233595/ Jyoti Nangalia Claire Harrison

Recent eJHaem study by @StephenOh & team challenges #myelofibrosis treatment evaluation, showing #momelotinib & #ruxolitinib improve #fibrosisgrades but not tangible benefit to survival/well-being. Time to expand response metrics? Details: onlinelibrary.wiley.com/doi/10.1002/jh…

Recent study showed how JAK2 mutations lead to MPNs for some, not others. Insights from @WellcomeSangerInstitute, @theUniversityofCambridge, and others feature the role of inherited DNA & a novel framework for understanding MPN development. @jyotinanglia. shorturl.at/jvAJ3

Believe in the power of patient voices shaping MPN research? We do. Their experiences drive patient-centered priorities, treatments, outcomes & more. Join us! Together we can make the greatest impact for those we aim to benefit. Share your story today: mpnrf.info/3P2JAX2

Our 2024 MPN Challenge™ awards are guided not only by the research itself, but by patient & caregiver insights, ensuring projects reflect real needs. Join us in funding impactful research informed by real stories. #MPNResearch #PatientInsights mpnrf.info/3P2JAX2

Industry & research professionals, how can we simplify complex terms for better patient dialogue when it comes to MPN research? Share your insights. mpnrf.info/3P2JAX2

March UtM is out! Read about UK study on skin cancer risks for MPN patients. Who develops which MPN and why? Join our community for more features and resources. mpnrf.info/3P2JAX2 Jyoti Nangalia #theunseenjourney #progressforpatiens .org

#Patientinvolvement in R&D isn't just beneficial; it's essential. By integrating #patientinsights , we ensure our efforts meet real #MPN needs, leading to more meaningful treatments & faster availability. Let's innovate together. mpnrf.info/3P2JAX2

While we continue our quest for novel treatments and eventually cure's for #ET , #PV , and #MF , we are thrilled that patients and their physicians have more tools in the toolbox to help live better lives. Options Matter.

MPN progression puzzles #patients , #clinicians , & industry alike. Our solution? Creating our #MPN Progression Research Network (PRN) Summit, fostering global collab and #cross -institutional #datasharing . Join our community now: mpnrf.info/3P2JAX2

Dr. John Crispino's Thrive initiative, with Dr. Ayalew Tefferi & team, has significantly advanced our understanding of MPN progression from MF to AML. This showcases the impact of collaborative expertise on complex medical challenges.